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A catchment area-based sample of patients recruited for an eating disorder treatment trial was compared
with patients from the same geographical area seen in the 12 months before and after the trial. The three
samples were very similar. The research sample was representative of the usual clinic sample fromwhich
it had been selected and thus the results could be extrapolated with some conﬁdence to other similar
clinical settings. It is concluded that whilst treatment trials, by their very nature, have explicit and
implicit inclusion and exclusion criteria with appropriate designs they can be usefully representative.
 2009 Elsevier Ltd.Open access under CC BY license.Introduction
Efﬁcacy studies, especially randomised controlled trials (RCT),
have been criticised; the most common objection being that they
select patients with one diagnosis only and have a large number of
exclusion criteria (Seligman, 1995), whereas in clinical practice
many patients have multiple problems and co-morbid disorders. In
1997 Mitchell et al. (Mitchell, Maki, Adson, Ruskin, & Crow, 1997)
hypothesized that the exclusion criteria employed in eating disorder
treatment trials (e.g., high suicide risk, substance abuse) remove
patients with a poor prognosis thereby inﬂating the apparent
response rate. However Wilson (1998) in an appraisal of such trials
concluded that they commonly included patients with levels of
disturbance as severe as those seen in routine clinical settings.
This paper describes a study that was designed to assess the
representativeness of patients treated for an eating disorder within
a randomised controlled trial (RCT) by comparing the trial sample
with patients seen in the same clinic before and after the period
of recruitment for the trial. Between 2002 and 2007 the long-
established Leicestershire Eating Disorder Service (LEDS) was one
centre in a two-site randomised controlled trial comparing two
forms of enhanced transdiagnostic cognitive behaviour therapy
(CBT-E) (Fairburn et al., 2008, 2009). Patients were randomised to
receiving one or other of these two therapies immediately or after
an 8 week delay, a waiting list control condition. The two license.treatments were designed to be suitable for adult patients with any
form of eating disorder of clinical severity provided only that they
were considered suitable for outpatient treatment. Length of
treatment was determined by the patient’s body mass index (BMI)
with those with a BMI over 17.5 receiving 20 weeks treatment and
those with a BMI of 17.5 or below receiving 40 weeks.
The LEDS is the only specialised assessment and treatment
service for adults with an eating disorder in the County of Leices-
tershire. It serves a total population of approximately one million.
However, the catchment area for the trial was a sub-sample
selected in advance by estimating the number of referrals needed to
populate the trial. Patients are referred to the LEDS by family
physicians and other clinicians. Thus patients referred to the service
had been ‘pre-screened’ by another medical professional and
deemed appropriate for a referral to a centre offering specialised
eating disorder treatment.
The sample was intended to be ‘‘inclusive’’ with few exclusion
criteria being applied (Fairburn et al., 2009). The selection criteria
were designed to replicate the clinical ﬁltering that takes place in
routine clinical practice when selecting patients for outpatient
treatment.
The speciﬁc aims of the present study were as follows:
1. To establish the referral rates of patients from the subsection of
the LEDS catchment area in one year epochs before, during and
after the trial;
2. To compare these three samples with respect to the propor-
tions of patients who met the trial inclusion and exclusion
criteria.
Table 1
Referral summary.
Year 2001
(before trial)
2003
(during trial)
2006
(after trial)
Signiﬁcance
Total referrals 101 96 105 c2¼ 0.617, df¼ 2, p¼ .734
Did not attend 26 (25.7%) 18 (18.8%) 21 (20.0%) c2¼ 1.646, df¼ 2, p¼ .439
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Design
To assess the representativeness of the trial sample, the char-
acteristics and disposition of the referrals to LEDs during a year
when the trial was recruiting (2003) were compared with those of
patients seen by the LEDS in the closest complete calendar years
before and after the trial (2001 and 2006).Table 2
Outcome of assessments for catchment area referrals 2001, 2003 and 2006.
Outcome of
consultation
2001
n¼ 75
2003
n¼ 78
2006
n¼ 84
Signiﬁcance
Eligible for treatment 56 (74.7%) 54 (69.2%) 56 (66.7%) c2¼ 1.245, df¼ 2,
p¼ .537
No eating disorder 12 (16.0%) 15 (19.2%) 14 (16.7%) c2¼ 0.364, df¼ 2,
p¼ .834
Referred to other services 2 (2.7%) 6 (7.6%) 11 (13.1%) c2¼ 5.860, df¼ 2,
p¼ .053
Not offered treatment 5 (6.7%) 3 (3.8%) 3 (3.6%) c2¼ 0.629, df¼ 2,
p¼ .794a
a Exact Pearson’s chi-square used.Selection of participants for the trial
The participants in the trial were selected from consecutive
referrals from a subsection of the catchment population of the
LEDS. Recruitment commenced in March 2002 and continued until
May 2005. The trial catchment area covered a population of
approximately 571,000. The inclusion criteria were as follows:
- Being a new referral or re-referral to the LEDS fromwithin the
trial catchment area.
- Having an eating disorder requiring treatment, as judged both
by the referring clinician and subsequently by the senior eating
disorder specialist at LEDS (RLP).
- Being between 18 and 60 years old.
- Having a body mass index between 16.0 and 39.9.
- Giving informed consent to participate in the trial.
The exclusion criteria may be divided into two categories, which
may be termed ‘‘practical’’ and ‘‘clinical’’ respectively. It is the
second group that is more relevant to the question of the extent to
which a trial may be representative, or not, of usual practice. The
practical exclusion criteria were as follows:
- Not having a permanent address in the trial catchment area.
- Not being sufﬁciently ﬂuent and literate in English to complete
interviews and questionnaires.
- Being unwilling, or unable, to attend for 20 or 40 sessions of
psychological treatment plus a possible additional waiting
period of 8 weeks.
The clinical exclusion criteria were:
- Being unwilling, or unable, to stop any other form of ongoing
psychotherapy.
- Being inappropriate to manage as an outpatient in the judge-
ment of the local senior clinician (RLP); for example being at
major risk of suicide.
- Having a physical condition judged likely to complicate the
interpretation of the trial’s ﬁndings (e.g., a weight-losing
illness, pregnancy). Other physical illnesses (e.g., diabetes
mellitus) were not exclusion criteria.
- Having a co-morbid axis I psychiatric disorder that required
immediate active treatment. Those with stable propensity for
instance a diagnosis of bipolar disorder were included but only
if they were currently euthymic.
- Having recently failed to respond to an evidence-based treat-
ment for the same DSM-IV eating disorder, delivered by
a specialist eating disorder service.
There was an initial screening of referrals by RLP. Those patients
who were clearly ineligible as judged by the content of the referral
letter (e.g., due to age, or location) were not assessed as part of the
trial and were managed as usual by the LEDS. The remainder were
seen for a ﬁrst assessment interview to determine their eligibility.Those who were deemed eligible were then offered treatment
within the context of the trial.Selection of the two comparison samples
Referrals from the same catchment area as the trial were iden-
tiﬁed. Two time periods were considered: the ﬁrst complete years
before the trial (January to December 2001) and immediately after
the trial (January to December 2006). The same inclusion and
exclusion criteria were applied, as far as was possible when
examining patient notes retrospectively.Results
Referral rates
Those patients who did not meet the age and BMI limits set for
the trial were excluded from the analysis (2001 n¼ 16, 2003 n¼ 20
and 2006 n¼ 18) and are not considered further. All subsequent
analyses relate to those who were potentially eligible.
As anticipated the referrals rates of such potentially eligible
patients before, during and after the trial period were similar (see
Table 1).
The proportion of patients eligible for treatment did not differ
signiﬁcantly over the three years (see Table 2). Similarly the
percentage of those who, on consultation, did not have an eating
disorder, were referred to other services or who were not offered
therapy did not differ signiﬁcantly in 2001 and 2006 from 2003.
The main reasons for patients not being offered treatment were
that they were moving away from the area or they did not return to
complete their assessment.
Fig. 1 summarises these ﬁgures in the form of a ﬂowchart.
In 2003, 8 patients (14.8%) (see shaded box in Fig. 1) from the
catchment area were not offered therapy within the treatment trial
andwere treatedwithin the LEDS. Themain reason for this was that
they could not commit to being available for the length of the trial
due to their anticipating changing address (n¼ 4). The other
reasons were: involvement with other services; weight having
dropped below a BMI of 16 by the time of assessment, and illiteracy.
There were no signiﬁcant differences in age, BMI, global EDEq
scores and general psychiatric features, as measured by the BSI,
between those offered therapy within the trial and the usual NHS
provision (Table 3). It is, of course, possible that there are
Fig. 1. Flowchart of catchment area referrals received in 2001, 2003 and 2006.
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characteristics which may have a bearing on treatment response.
Themain diagnosis for each of the groups was EDNOS, representing
60% (n¼ 27) of those treated within the trial and 87.5% (n¼ 7) of
those treated within the NHS.
Discussion
Can treatment trials be representative? The question may need
to be broken in to two. Firstly, to what extent does the recruitment
and pathway to the trial resemble the usual recruitment and
pathway to treatment in the particular clinic or setting within
which the research treatments are being offered? And secondly, to
what degree does that clinic or setting reﬂect the universe of
relevant clinics or settings? Those who are sceptical about the
utility of trials may raise doubts in relation to either or both
questions. Thus it is not uncommon for a trial to recruit by adver-
tisement and screening, and then to offer free treatment within
a special research unit but only to people with full syndrome
disorders and no co-morbidity. In some circumstances research
based care may be an affordable alternative for those withoutTable 3
Clinical characteristics of patients offered therapy.
Offered trial therapy, N¼ 46, mean (SD)
Age 25.5 (6.8)
BMI 22.5 (4.2)
Global EDEqa 4.28 (1.12)
BSIb 1.94 (0.8)
a Eating Disorder Examination Questionnaire (Fairburn & Beglin, 1994).
b Brief Symptom Inventory (Derogatis & Spencer, 1982).adequate insurance coverage. It is possible that such patients might
have higher rates of medical or psychiatric co-morbid conditions
that would make them less appropriate for care within a study
protocol. Rates of transience and illiteracy might also affect take up
and response. Nevertheless, research with samples recruited in this
way may yield useful results. However, there can be only modest
conﬁdence about the extent to which the ﬁndings can be general-
ised to, say, the practice of a clinician working alone with patients
who fund their own treatment and who have been referred
regardless of ‘‘purity’’ of the diagnosis. Of course, it is the shared
diagnosis that allows of any useful generalisation at all. It ensures
that recruits to the trial and referrals to the clinic have similar core
symptoms even if they differ in most other respects. Such lack of
resemblance may perhaps not matter much for some disorders,
such as cholecystitis, cataract or cervical cancer, but for most
mental disorders, including eating disorders, such issues are likely
to be important. Furthermore, reliance upon diagnosis alone as the
basis of generalisation is more questionable where the relevant
diagnostic systems are themselves seriously ﬂawed, as is the case
with the eating disorders (Fairburn & Bohn, 2005; Fairburn, Cooper,
Bohn, O’Connor, Doll, & Palmer, 2007; Nielsen & Palmer, 2003).Offered NHS therapy, N¼ 8, mean (SD) Signiﬁcance
27.6 (5.2) t¼ .837, df¼ 51, p¼ .406
23.2 (7.2) t¼ .408, df¼ 51, p¼ .685
3.52 (1.49) z¼ 1.3, p¼ .207
2.34 (0.8) t¼ 1.007, df¼ 43, p¼ .320
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implied in either question. The method of recruitment, the terms of
treatment, and the exclusion of many subjects because of the strict
use of diagnostic criteria may not represent usual practice even
within a specialised clinic and that clinic will not resemble at all
closely the universe of clinics offering treatment for those with the
relevant disorders.
So, treatment trials are often not representative in the relevant
senses but can they be made to be? Or is there something inherent
to treatment trials that makes them inevitably unrepresentative.
Some patients dislike the very idea of taking part in research. They
do not want to be ‘‘guinea pigs’’. Furthermore, the usually detailed
consent procedures may be off-putting. All trials must have explicit
inclusion criteria whereas this is not always the case for services or
practices some of which use ﬂexible and implicit criteria. And yet to
avoid speciﬁed inclusion criteria would be to throw the baby out
with the bath water. Much important progress in treatment
research has been made because of the use of well-deﬁned
recruitment criteria.
The Leicester arm of the research was embedded in a well
established specialist eating disorder service for adults which is
a provision of the UK National Health Service for a deﬁned catch-
ment area. For those people referred to the service the trial treat-
ments were offered to all potential patients subject to their meeting
the broad criteria of the study and giving informed consent. Thus
the trial treatments largely replaced the usual provision during the
time of the trial. Recruitment of a sample for the trial that was
closely representative of the usual clinical population was aided by
the service (LEDS) being a near monopoly provider of the relevant
type of care. Also the treatment offered in the trial did not differ
much from the usual treatment offered in the service. Both the trial
and usual practice offered time limited individual, face to face
therapy. Had the trial involved a completely different type of
treatment this might have affected take up and completion rates.
Reassuringly with respect to the aspiration for the trial to be
representative of the usual running of a clinical service, the cohorts
of patients referred before, during and after the trial did not differ
signiﬁcantly in terms of their number, meeting the eligibility
criteria for the trial, and their overall take up and completion of
treatment. During the trial year studied (2003) of the 78 actually
seen and assessed 28 completed treatment, of which 21 were in the
trial. Such data presented in a CONSORT diagrammight be thoughtof as evidence of the selectivity of research samples. However, it is
important to note that comparison with the non-research cohorts
presenting from the same catchment area in the years before and
after the trial demonstrates that the proportion of people
completing treatment was remarkably similar (Fig. 1).
We consider that this study demonstrates that treatment trials
can be usefully representative although the degree to which they
are depends upon the details of design. We recommend that
reports of treatment trials should include consideration and
discussion of the ways in which their samples resemble and differ
from those usually seen in clinical practice.Acknowledgements
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